Lipid core peptide technology and group A streptococcal vaccine delivery.
about
Immunological evaluation of lipopeptide group A streptococcus (GAS) vaccine: structure-activity relationshipNovel strategies for controlling Streptococcus pyogenes infection and associated diseases: from potential peptide vaccines to antibody immunotherapy.Investigation of structure-activity relationships of synthetic anti-gonadotropin releasing hormone vaccine candidates.Multilayer engineered nanoliposomes as a novel tool for oral delivery of lipopeptide-based vaccines against group A Streptococcus.
P2860
Lipid core peptide technology and group A streptococcal vaccine delivery.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Lipid core peptide technology and group A streptococcal vaccine delivery.
@ast
Lipid core peptide technology and group A streptococcal vaccine delivery.
@en
type
label
Lipid core peptide technology and group A streptococcal vaccine delivery.
@ast
Lipid core peptide technology and group A streptococcal vaccine delivery.
@en
prefLabel
Lipid core peptide technology and group A streptococcal vaccine delivery.
@ast
Lipid core peptide technology and group A streptococcal vaccine delivery.
@en
P2860
P356
P1476
Lipid core peptide technology and group A streptococcal vaccine delivery
@en
P2093
Colleen Olive
Michael R Batzloff
P2860
P356
10.1586/14760584.3.1.43
P50
P577
2004-02-01T00:00:00Z